| Financial Year |
March 31 2023 |
| Monetary Funds |
963,097,630.67 |
| Held-for-trading Financial Assets |
20,000,000.00 |
| Notes Receivable |
35,016,176.72 |
| Accounts Receivable |
353,065,445.60 |
| Advances to Suppliers |
4,326,943.38 |
| Other Receivables |
12,836,365.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
197,216,091.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,348,198.22 |
| Total Current Assets |
1,618,906,850.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
510,442,629.12 |
| Under-construction Projects |
25,264,575.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,674,976.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
36,169,539.71 |
| Deferred Income Tax Assets |
9,923,018.12 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
644,371,451.71 |
| Total Assets |
2,263,278,302.57 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
81,078,735.59 |
| Accounts Payable |
157,120,837.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,636,319.13 |
| Taxes Payable |
5,181,561.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,945,415.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,245,098.34 |
| Other Current Liabilities |
19,176,575.10 |
| Sub-Total of Current Liabilities |
336,438,746.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,445,799.18 |
| Total Liabilities |
346,884,545.31 |
| Paid-In Capital(Or Share Stock) |
413,380,000.00 |
| Capital Surplus |
874,156,153.44 |
| Surplus Reserve |
106,904,824.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
520,019,679.67 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,916,393,757.26 |
| Owner's Equity（Stockholder's Equity） |
1,916,393,757.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,263,278,302.57 |
